AC Immune SA

From Verify.Wiki
Jump to: navigation, search
AC Immune SA
Type Public
Industry Biotechnology
Founded 2003
Headquarters Lausanne, Switzerland
Key people Andrea Pfeifer (Co-Founder & CEO), Jean-Fabien Monin (CFO), Andreas Muhs (CSO) [1]
Investors Dietmar Hopp
Number of employees 62 [2]

AC Immune SA, a clinical stage Swiss-based biopharmaceutical company, focuses on neurodegenerative diseases with three product candidates in clinical trials. It designs, discovers, and develops therapeutic and diagnostic products intended to prevent and modify diseases caused by misfolding proteins. The company’s technology platforms create antibodies, small molecules, and vaccines to address a broad spectrum of neurodegenerative indications. It offers its therapies to address Alzheimer disease and neurodegenerative diseases, such as Parkinson’s, Down syndrome, and glaucoma.
AC Immune SA was founded in 2003 and is based in Lausanne, Switzerland. [3]



Top 5 Recent Tweets

February 07, 2023AC_Immune_SAWe are pleased to announce two new grants, one from the Michael J. Fox Foundation for Parkinson’s Research and one…
February 03, 2023AlzheimerEurope.@AC_Immune_SA announced initial interim safety and immunogenicity data from its ABATE Phase 1b/2 #clinicaltrial of…
February 02, 2023AC_Immune_SAJoin AC Immune’s CEO Dr. Andrea Pfeifer, on February 14th, for a Fireside chat at the SVB Securities Global Biophar…
January 30, 2023fundamentalsbotAC Immune SA's quarterly revenue growth rate YoY of -11.10% ranked 3475 out of 5735 companies in our database.…

Top 5 Recent News Headlines

Top 5 Lifetime Tweets

Top 5 Lifetime News Headlines


Verification history